Bones

BONESUPPORT is a leading commercial-stage orthobiologics company that develops innovative injectable bioceramic bone graft substitutes. The company's proprietary CERAMENT platform is designed to remodel into native bone and has the unique capability to elute drugs, such as antibiotics, directly into the bone void to prevent or treat infections. Their flagship products, CERAMENT G and CERAMENT V, are the first CE-marked and FDA-approved injectable antibiotic-eluting bone grafts, significantly improving outcomes for patients with bone infections and complex fractures. Headquartered in Sweden, BONESUPPORT serves a global market, focusing on trauma, chronic osteomyelitis, and orthopedic revision surgery.